استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

Remote diagnostics greatly influence the accessibility and quality of healthcare

BioSpectrum Indian Feb 2025

|

Bio Spectrum

The healthcare industry has undergone tremendous change thanks to remote diagnostics. These enable healthcare providers to provide diagnostic services to patients in even the most remote locations by utilising digital tools and telecommunication technologies. The accessibility and quality of healthcare will be significantly impacted by remote diagnostics, but to assure universal use, a few problems must be resolved.

Remote diagnostics greatly influence the accessibility and quality of healthcare

T The diagnostics industry in India is growing rapidly, driven by growing healthcare awareness, an increasing prevalence of chronic diseases and lifestyle disorders, and advancements in technology. It encompasses pathology labs, imaging centres, and specialised diagnostic services - all of which contribute significantly to the healthcare sector.

Key trends in this area include the adoption of digital diagnostics, AI-powered tools, point-ofcare testing, and a surge in home-based diagnostic services and telemedicine. Despite regulatory hurdles and infrastructure gaps, the Indian diagnostics market is poised for substantial growth, improving accessibility and quality of healthcare across the country.

Recent technology developments, particularly in remote diagnostics, have significantly altered the healthcare landscape. These allow medical professionals to reach patients in even the most remote areas using digital tools and telecommunication technologies to deliver diagnostic services. Remote diagnostics will have a significant impact on healthcare accessibility and quality, but there are certain issues that need to be addressed to ensure widespread adoption.

Impact of Remote Diagnostics on Healthcare Accessibility

One of the most significant benefits of remote diagnostics is improving accessibility of healthcare services to the underserved and vulnerable populations such as elderly people, immobile, disabled individuals, and residents of less economically developed areas. In many rural and remote regions of India, people have limited access to healthcare and specialised doctors. Distant diagnostics bridges the gap by providing patients with timely diagnostic services, eliminating the need to travel long distances in emergent situations.

المزيد من القصص من Bio Spectrum

Bio Spectrum

Bio Spectrum

Navigating the Complexities of Pharma Packaging Sustainability

Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.

time to read

8 mins

September 2025

Bio Spectrum

Bio Spectrum

Are BioStartUps in a Funding/Innovation Rut?

At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.

time to read

10 mins

September 2025

Bio Spectrum

Bio Spectrum

How Do Recent Deaths Impact Gene Therapy Development?

Cell and gene therapy (CGT) is among the most closely watched areas in pharma and biotech.

time to read

4 mins

September 2025

Bio Spectrum

Bio Spectrum

HealthQuad appoints Namit Chugh as Director

Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Why Is Endoscopy Crucial for Gl Cancer Diagnosis?

The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.

time to read

4 mins

September 2025

Bio Spectrum

New England Biolabs launches NEBNext low-bias small RNA library prep kit

US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels

Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"

India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.

time to read

4 mins

September 2025

Bio Spectrum

Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India

In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr

Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.

time to read

1 min

September 2025

Listen

Translate

Share

-
+

Change font size